Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results

3/4, 3 d on, 4 d off; 5/2, 5 d on, 2 d off; CN, copy number; CRC, colorectal cancer; HomDel, homozygous deletion; M, module; TCGA, …